Table of Contents
AI patient intake company MiiHealth AI has secured $2.8 million in seed funding to accelerate development and deployment of its agentic AI medical assistant, DAINA. The Phoenix-based startup is building technology designed to complete patient intake before appointments, collect structured clinical information, and prepare documentation for clinicians. The funding is expected to support engineering expansion, deeper electronic health record integrations, additional clinical protocols, and broader adoption across healthcare organizations.
The investment comes as hospitals and physician practices continue looking for ways to reduce administrative work while allowing clinicians to spend more time directly with patients. MiiHealth AI is positioning automated intake as one area where artificial intelligence could provide measurable workflow benefits without replacing clinical decision-making.
AI Patient Intake Startup Raises $2.8 Million
MiiHealth AI’s $2.8 million seed round was led by Russell Glass, former CEO of Headspace and founder of Arteria Capital. The financing also included participation from physician angel investors, healthcare operators, and digital health founders, according to the company’s funding announcement.
The new capital provides MiiHealth AI with resources to move beyond early clinical validation and expand its product across larger healthcare environments.
The company’s primary technology is DAINA, short for Dynamic AI Intake and Navigation Agent. Rather than functioning as a conventional digital questionnaire, DAINA conducts a conversational intake with patients before they see their healthcare provider.
The platform is designed to collect relevant symptoms, clinical history, medication information, treatment goals, and potential warning signs while following protocols tailored to the patient’s medical specialty.
AI Patient Intake Automates Pre-Visit Work
DAINA contacts patients before their scheduled appointments and carries out a multi-step clinical conversation. Patients can answer questions through a voice-based interaction instead of completing only static forms.
MiiHealth AI says the system can communicate with patients in their preferred language, gather structured medical histories, and convert the conversation into clinician-ready documentation. The resulting note can then be delivered into the patient’s electronic health record.
This workflow is intended to shift repetitive data collection away from the examination room. Instead of spending the opening portion of a visit gathering basic history, clinicians can begin the encounter with key information already organized.
The approach could be particularly useful in specialties where detailed histories are necessary before treatment decisions can be made.
AI Patient Intake Funding Supports Expansion
MiiHealth AI plans to use the seed funding across several areas of its business.
The company intends to expand its engineering and artificial intelligence teams, increase the number of specialty-specific protocols supported by DAINA, and strengthen the platform’s clinical reasoning and safety capabilities. It also plans to accelerate integrations with major EHR platforms and healthcare infrastructure.
Commercial expansion represents another priority. MiiHealth AI plans to grow its customer success and commercial teams as it targets health systems, specialty medical practices, and virtual-first healthcare providers.
These investments indicate that the company is moving from product validation toward broader implementation.
Scaling healthcare AI, however, requires more than demonstrating that an algorithm works. Products must integrate into existing clinical workflows, meet healthcare security requirements, reliably exchange information with EHR platforms, and generate information that clinicians can quickly review.
AI Patient Intake Needs Strong EHR Integration
Electronic health record integration could become one of the most important elements of MiiHealth AI’s growth strategy.
Healthcare providers generally want new technologies to operate within existing clinical systems rather than requiring staff to copy information between separate applications.
MiiHealth AI says its platform can generate structured, EHR-ready intake notes and connect with major systems using healthcare interoperability standards, including HL7v2.
Modern interoperability standards are increasingly important as digital health companies connect applications to EHR platforms. HealthIT.gov notes that Fast Healthcare Interoperability Resources, or FHIR, provides a standardized approach for exchanging electronic healthcare information across systems.
The ability to place useful clinical information directly into existing workflows may influence whether healthcare organizations can deploy AI tools without creating additional administrative work.
Mayo Clinic Testing Supports Clinical Validation
MiiHealth AI has also tested DAINA in collaboration with Mayo Clinic. Phoenix Business Journal reported that the startup’s AI assistant was being tested with Mayo Clinic as the company prepared to use its new funding for engineering expansion and EHR integrations.
According to MiiHealth AI’s funding announcement, DAINA completed intake for hundreds of patients during a cardiology deployment at Mayo Clinic. The company says the implementation produced measurable provider time savings while patients reported high levels of comfort using the technology.
MiiHealth AI reports that the platform saved more than eight minutes per cardiology encounter in this setting. Its website similarly states that providers save an average of more than eight minutes per patient visit.
These figures are company-reported results and should not automatically be interpreted as outcomes that every health system will achieve. Workflow benefits can vary based on specialty, appointment complexity, EHR configuration, staffing practices, patient population, and implementation design.
Still, even relatively small time savings can become meaningful when multiplied across dozens of patients and hundreds of clinicians.
Automated Intake Could Reduce Administrative Work
Clinical administrative burden is one of the primary problems MiiHealth AI hopes to address.
Traditional patient intake can involve registration forms, medication reconciliation, symptom review, previous medical history, visit objectives, and condition-specific questions. When this information is incomplete before an appointment, physicians, nurses, or medical assistants may need to collect it during the visit.
DAINA attempts to move more of this activity upstream.
The company says automating intake can return more than two hours per day to providers who would otherwise spend that time conducting repetitive questioning and documentation.
Its website also estimates potential improvements in provider productivity and patient throughput when the reported per-visit savings are applied at scale. These calculations are based on assumptions provided by MiiHealth AI and should be evaluated by individual organizations using their own clinical and financial data.
AI Patient Intake Could Expand Capacity
Reducing intake time may create several possible benefits.
Clinicians could use the recovered time to spend longer discussing complex medical concerns, complete documentation earlier, accommodate additional visits, or reduce work carried into evenings.
Healthcare organizations could also potentially increase capacity without increasing staffing at the same rate.
However, additional appointment capacity should not be the only measure of success. Automated intake should also be evaluated for clinical accuracy, patient satisfaction, staff acceptance, accessibility, documentation quality, safety, and the ability to recognize when human intervention is required.
Multilingual AI Could Improve Patient Experience
DAINA’s multilingual capabilities are another important element of the platform.
MiiHealth AI says patients can participate in intake conversations using their preferred language. This could make the process more accessible for people who find lengthy medical forms difficult to complete or who communicate more comfortably through conversation.
Voice-based intake may also allow the system to collect more contextual information than a traditional checklist.
However, multilingual healthcare AI requires rigorous testing. Medical terminology, regional language differences, accents, ambiguous responses, and culturally specific descriptions of symptoms can influence interpretation.
Healthcare organizations adopting these systems will need appropriate safeguards for situations where the AI is uncertain or where a patient’s response indicates an urgent medical problem.
Healthcare AI Must Prioritize Safety
MiiHealth AI says part of the new funding will be directed toward strengthening DAINA’s clinical reasoning and safety checks.
That investment will be important as automated medical conversations move deeper into clinical workflows.
AI-generated intake documentation must accurately represent what the patient communicated. Incorrect summaries, missing symptoms, or information placed in the wrong EHR field could create downstream clinical risks.
Healthcare organizations therefore need processes for reviewing AI-produced documentation, monitoring performance, handling errors, protecting patient information, and determining which tasks require human oversight.
Trust is particularly important because patient intake can include sensitive information related to medical history, medications, symptoms, mental health, reproductive health, and other personal matters.
MiiHealth AI Targets Broader Deployment
MiiHealth AI’s seed round represents a transition from early validation toward commercial scale.
The company is seeking to broaden its specialty protocol library, strengthen its underlying technology, expand EHR connectivity, and support healthcare organizations deploying automated intake across multiple departments.
The opportunity is substantial because intake is common across nearly every outpatient healthcare setting. However, the market is also likely to demand clear evidence of return on investment, clinical safety, reliability, patient acceptance, cybersecurity, and workflow compatibility.
MiiHealth AI’s ability to integrate without requiring physicians to radically change how they practice could become an important differentiator.
The company’s reported Mayo Clinic experience provides an early example of how the technology might function in a major healthcare setting, but broader deployments will provide more evidence about performance across different specialties and patient populations.
AI Patient Intake Enters Growth Phase
The $2.8 million financing gives MiiHealth AI additional resources to test whether conversational AI can turn patient intake from an administrative bottleneck into a more automated part of clinical care.
DAINA’s model is straightforward: gather the patient’s story before the clinician enters the room, organize the information, and make it available inside the workflow where providers already work.
If the technology can consistently save time while maintaining clinical quality, protecting sensitive information, and integrating smoothly with EHR systems, AI patient intake could become an increasingly common part of outpatient healthcare.
MiiHealth AI’s next stage will therefore be about more than expanding its technology. The company will need to demonstrate that its reported efficiency gains can be reproduced across larger health systems, different specialties, and diverse patient populations.
For healthcare leaders, the broader development highlights an important direction for artificial intelligence: some of its most immediate value may come not from replacing complex clinical judgment, but from automating repetitive work surrounding the patient encounter.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
